Urinary tract infections (UTIs) are a common type of infection caused by bacteria (most often E. coli) that travel up the urethra to the bladder. A bladder infection is called cystitis. If bacterial infection spreads to the kidneys and ureters, the condition is called pyelonephritis. Cystitis is considered a lower urinary tract infection. Pyelonephritis is an upper urinary tract infection and is much more serious.
Women are more susceptible to UTIs than men, and their infections tend to recur. One reason is that the urethra (the tube that carries urine away from the bladder) is shorter in women than in men. Frequent sexual intercourse also increases a woman's risk of developing UTIs. Contraceptive spermicides and diaphragms are additional risk factors. When women reach menopause, the decrease in estrogen thins the lining of the urinary tract, which increases susceptibility to bacterial infections.
Pregnancy does not increase the risk of getting a UTI, but it can increase the risk of developing a serious infection that could potentially harm the mother and fetus. Pregnant women should report any symptoms of UTIs to their doctors, and should get screened and treated for asymptomatic bacteriuria (presence of significant numbers of bacteria in the urine without symptoms).
Symptoms of UTIs may include:
A urine test can determine if these symptoms are caused by a bacterial infection. Antibiotics are used to treat UTIs. Older people may have a urinary tract infection but have few or no symptoms.
Antibiotics are used to treat UTIs. Most cases of UTIs clear up after a few days of drug treatment, but more severe cases may require several weeks of treatment.
Guidelines recommend using nitrofurantoin or trimethoprin-sulfamethoxazole as first-line antibiotic treatments for UTIs. Fluoroquinolones (such as ciprofloxacin) are now only recommended when other antibiotics are not appropriate.
Cranberry juice appears to offer little benefit for preventing recurrent UTIs, according to a review by the Cochrane Collaboration. Other studies have suggested that cranberry products may be helpful by preventing harmful bacteria from attaching and sticking to urinary tract cells.
Babies rarely get UTIs but when they do, these infections are much more common in boys than in girls. A recent policy statement from the American Academy of Pediatrics (AAP), and a review of research studies in the Journal of Urology, indicate that boys who are circumcised are far less likely to get UTIs during their first year of life than uncircumcised boys. While noting the many potential health benefits of male circumcision (including reduced risks for acquiring sexually transmitted diseases), the AAP recommends that the decision to circumcise should be left to parents, in consultation with their child's doctor.
A urinary tract infection (UTI) is a condition in which one or more parts of the urinary system (the kidneys, ureters, bladder, and urethra) become infected. UTIs are among the most common of all bacterial infections and can occur at any time of life. Nearly 95% of cases of UTIs are caused by bacteria that typically multiply at the opening of the urethra and travel up to the bladder. Much less often, bacteria spread to the kidney from the bloodstream.
The male and female urinary tracts are similar except for the length of the urethra.
The urinary system helps maintain proper water and salt balance throughout the body and also expels urine from the body. It is made up of the following organs and structures:
Infection does not always occur when bacteria are introduced into the bladder. A number of defense systems protect the urinary tract against infection-causing bacteria:
UTIs are generally classified as:
Uncomplicated UTIs are due to a bacterial infection, most often caused by E coli. UTIs affect women much more often than men.
Complicated infections, which occur in men and women of any age, are also caused by bacteria but they tend to be more severe, more difficult to treat, and more likely to recur. They are often the result of:
Recurrences can occur in people with complicated UTI if the underlying structural or anatomical abnormalities are not corrected.
Most women who have had an uncomplicated UTI have occasional recurrences. Many of these women get another infection within a year of the previous one. A much smaller number of women have ongoing, recurrent urinary tract infections, which follow the resolution of a previous treated or untreated episode.
Recurrence is often categorized as either reinfection or relapse:
An asymptomatic UTI (also called asymptomatic bacteriuria) is when a person has no symptoms of infection but has a significant number of bacteria that have colonized the urinary tract. The condition is harmless in most people and rarely persists, although it does increase the risk for developing symptomatic UTIs.
Screening and treatment of asymptomatic bacteriuria is not usually necessary except for the following people:
Bacteria that cause UTIs include:
Recurring infections are often caused by different bacteria than those that caused a previous or first infection.
Changes in the amount or type of acid within the genital and urinary tracts contribute to lowering the resistance to infection. For example, beneficial organisms called lactobacilli increase the acidic environment in the female urinary tract and thereby reduce the risk of infection.
UTIs are far more common among women than among men. Most women will develop a UTI at some time in their lives, and many will have recurrences.
In general, the higher risk in women is mostly due to the shortness of the female urethra, which is 1.5 inches compared to 8 inches in men. Bacteria from fecal matter at the anal opening can be easily transferred to the opening of the urethra.
The female and male urinary tracts are similar except for the length of the urethra.
Frequent or recent sexual activity is the most important risk factor for UTIs in young women. Nearly 80% of all UTIs in premenopausal women occur within 24 hours of intercourse. UTIs are very rare in celibate women. However, UTIs are
In general, it is the physical act of intercourse itself that produces conditions that increase susceptibility to the UTI bacteria, with some factors increasing the risk. For example, women having sex for the first time or who have intense or frequent sex are at risk for a condition called "honeymoon cystitis."
Certain types of contraceptives can also increase the risk of UTIs. In particular, women who use diaphragms tend to develop UTIs. The spring-rim of the diaphragm can bruise the area near the bladder, making it susceptible to bacteria. Spermicidal foam or gel used with diaphragms, and spermicidal-coated condoms, also increase susceptibility to UTIs. Most spermicides contain nonoxynol-9, a chemical that is associated with increased UTI risk.
In pregnant women, the presence of asymptomatic bacteriuria is associated with increased risk of kidney infection, which can cause early labor and other serious pregnancy complications. For this reason, pregnant women should be screened and treated for asymptomatic bacteriuria. Pregnant women are more susceptible to kidney infection because as the uterus enlarges it compresses the ureters and bladder. This causes urine to back up into the kidney, increasing the risk of bacterial infection.
The risk for UTIs, both symptomatic and asymptomatic, is highest in women after menopause. This is primarily due to decrease in estrogen, which thins the walls of the urinary tract and reduces its ability to resist bacteria. Estrogen loss can also reduce certain immune factors in the vagina that help block E. coli from attaching to vaginal cells. For some women, topical estrogen therapy helps restore healthy bacteria and reduce the risk of recurrent UTIs. (Oral hormone replacement therapy is not helpful for UTIs.)
Other aging-related urinary conditions, such as urinary incontinence, can increase the risk for recurrent urinary tract infections.
Women who have skin allergies to ingredients in soaps, vaginal creams, bubble baths, or other chemicals that are used in the genital area are at increased risk for UTIs. In such cases, the allergies may cause small injuries that can introduce bacteria.
Antibiotics often eliminate lactobacilli, the protective bacteria, along with harmful bacteria. This can cause an overgrowth of E. coli in the vagina.
Men become more susceptible to UTIs after age 50, when they begin to develop prostate problems. Benign prostatic hyperplasia (BPH), enlargement of the prostate gland, can produce obstruction in the urinary tract and increase the risk for infection. In men, recurrent UTIs are also associated with prostatitis, an infection of the prostate gland. Although UTIs are less common in men, they can cause more serious problems in men than in women. Men with UTIs are more likely to require hospitalization than women.
UTIs are rare during infancy but they are much more common in boys than in girls. Boys who are circumcised are far less likely than uncircumcised boys to develop UTIs by the time they are 1 year old. After the age of 2 years, UTIs are more common in girls. As with adults, E. coli is the most common cause of UTIs in children.
Vesicoureteral reflux (VUR) is the cause of up to half of the UTIs that occur during childhood. VUR also puts children at risk for UTI recurrence.
VUR is a condition in which the urine backs up into the kidneys. Normally, urine travels from the kidneys through the ureters, and into the bladder. When the bladder becomes filled, the muscle in the bladder wall contracts, and the urine leaves the body through another tube called the urethra. There is a valve-like mechanism at the point where the ureters join the bladder. The job of these valves is to keep urine from flowing backward towards the kidneys when the bladder contracts. If the valves do not work well, urine may remain in the bladder where bacteria can grow. The back flow of urine may also carry any infection from the bladder up into the kidneys.
A child may be:
Most UTIs that develop in hospitalized people are due to urinary catheters. The longer any urinary catheter is in place, the higher the risk for growth of bacteria and an infection. In most cases of catheter-induced UTIs, there are no symptoms. However, due to the risk for wider infection, anyone requiring a catheter should be screened for infection. Catheters should be used only when necessary and should be removed as soon as possible.
All older adults who are immobilized, catheterized, or dehydrated are at increased risk for UTIs. Nursing home residents, particularly those who are incontinent, are at very high risk.
Diabetes (type 1 and type 2) puts women at significantly higher risk for asymptomatic bacteriuria. The longer a woman has diabetes, the higher the risk. Control of blood sugar does not affect the risk for this condition. The risk for UTI complications, and fungal-related UTIs, is also higher in people with diabetes.
Nearly any kidney disorder, including kidney stones, increases the risk for complicated UTIs.
A number of brain and nerve disorders can affect the nerves of the bladder and cause problems with the ability to empty the bladder and control urine leakage. Multiple sclerosis, stroke, spinal cord injury, and diabetic neuropathy are common examples.
People with immunocompromised systems, such as those who have HIV/AIDS or who are undergoing treatment for cancer, are at increased risk for all types of infections, including UTIs and pyelonephritis.
Some people have structural abnormalities of the urinary tract that cause urine to stagnate or flow backward into the upper urinary tract. A prolapsed bladder (cystocele) can result in incomplete urination so that urine collects, creating a breeding ground for bacteria. Tiny pockets called diverticula sometimes develop inside the urethral wall and can collect urine and debris, further increasing the risk for infection.
In most cases, UTIs are annoyances that cause urinary discomfort. However, if left untreated, UTIs can develop into very serious and potentially life-threatening kidney infections (pyelonephritis) that can permanently scar or damage the kidneys. The infection may also spread into the bloodstream (called sepsis) and elsewhere in the body.
UTIs in pregnant women pose serious health risks for both mother and child. UTIs that occur during pregnancy have a higher than average risk of developing into kidney infections. Any pregnant woman who suspects she has a UTI should immediately contact her doctor. Many doctors recommend that women receive periodic urine testing throughout their pregnancies to check for signs of bacterial infection.
In some adults, recurrent UTIs may cause scarring in the kidneys, which over time can lead to renal hypertension and eventual kidney failure. Most of these adults with kidney damage have other predisposing diseases or structural abnormalities. Recurrent UTIs almost never lead to progressive kidney damage in otherwise healthy women.
Scarring and future kidney problems are concerns for children who experience severe or multiple kidney infections.
Symptoms of lower UTIs usually begin suddenly and may include one or more of the following signs:
Symptoms of kidney infections tend to affect the whole body and be more severe than those of cystitis (inflammation of the bladder and ureters). They may include:
UTIs in infants and preschool children tend to be more serious because they are more likely to involve the kidneys. Older children are more likely to have lower UTIs and standard symptoms. Infants and young children should always be checked for UTIs if the following symptoms are present:
The classic lower UTI symptoms of pain, frequency, or urgency and upper tract symptoms of flank pain, chills, and tenderness may be absent or altered in older people with UTIs.
Symptoms of UTIs that may occur in seniors but not in younger adults include mental changes or confusion, nausea or vomiting, abdominal pain, or cough and shortness of breath. A preexisting health condition may further confuse the picture and make diagnosis difficult.
A doctor can confirm if you have a UTI by testing a sample of your urine. For some younger women who are at low risk of complications, the doctor may not order a urine test and may diagnose a UTI based on the description of symptoms.
A urinalysis is an evaluation of various components of a urine sample. It involves looking at the urine color and clarity, using a special dipstick to do different chemical testing, and possibly inspecting some of the urine underneath a microscope. A urinalysis usually provides enough information for a doctor or nurse to start treatment.
If necessary, the doctor may order a urine culture, which involves incubating and growing the bacteria contained in the urine. A urine culture can help identify the specific bacteria causing the infection, and determine which type of antibiotics to use for treatment. A urine culture may be ordered if the urinalysis does not show signs of infection but the doctor still suspects a UTI is causing the symptoms. It may also be ordered if the doctor suspects complications from the infection.
To obtain an untainted urine sample, doctors usually request a so-called midstream, or clean-catch, urine sample. Here are some tips for providing an accurate sample:
Some people (small children, elderly people, or hospitalized people) cannot provide a urine sample. In such cases, a catheter may be inserted into the bladder to collect urine. This is the best method for providing a contaminant-free sample, but it carries a risk of introducing or spreading infection.
If the infection does not respond to treatment, the doctor may order other tests to determine what is causing symptoms. Imaging tests such as ultrasound and computed tomography (CT scan) may help identify:
Special x-rays can be used to screen for structural abnormalities, urethral narrowing, or incomplete emptying of the bladder:
Cystoscopy is used to detect structural abnormalities, interstitial cystitis (painful bladder syndrome), or masses that might not show up on x-rays during an IVP. The person is given a light anesthetic and the bladder is filled with water. The procedure uses a cystoscope, a flexible, tube-like instrument that the urologist inserts through the urethra into the bladder.
If the person has fever or other signs of a serious infection, the doctor will order blood cultures to determine if the infection has entered the bloodstream and is threatening other parts of the body.
About half of women with symptoms of a UTI actually have some other condition, such as irritation of the urethra, vaginitis, interstitial cystitis, or sexually transmitted diseases (STDs). Some of these problems may also accompany or lead to UTIs.
Vaginitis is inflammation of the vagina. It is commonly by a yeast infection (candidiasis) or bacterial infection (vaginosis). Occasionally, the infection causes frequent urination, mimicking cystitis. The typical symptoms of vaginitis are itching and an abnormal discharge.
Women with painful urination whose urine does not exhibit signs of bacterial growth in culture may have a STD. The most common microorganism is Chlamydia trachomatis. Other STDs that may be responsible include gonorrhea and genital herpes.
Interstitial cystitis (IC), also known as painful bladder syndrome, is an inflammation of the bladder wall that occurs almost predominantly in women. Symptoms are very similar to cystitis, but no bacteria are present. Pain during sex is a very common complaint in these patients, and stress may intensify symptoms.
The pain of kidney stones along with blood in the urine can resemble the symptoms of pyelonephritis. However, there are no bacteria present with kidney stones.
Problems that might cause painful urination in children include reactions to chemicals in bubble bath, diaper rashes, and infection from the pinworm parasite.
Prostate conditions, including prostatitis (inflammation of the prostate) and BPH, can cause symptoms similar to UTIs.
Excess sugar in the urine can have a diuretic effect, thereby causing frequent urination.
Antibiotics are the main treatment for UTIs. A variety of antibiotics are available, and choices depend on many factors, including whether the infection is complicated or uncomplicated or primary or recurrent. Treatment decisions are also based on the type of person (man or woman, a pregnant or nonpregnant woman, child, hospitalized or nonhospitalized person, or person with diabetes).
Due to the recent increase of drug-resistant bacteria, a doctor may also select an antibiotic based on the resistance rate in that geographic area.
UTIs can often be successfully treated with antibiotics prescribed over the phone. In such cases, a health professional provides the people with 3-day antibiotic regimens without requiring an office urine test. This course is recommended only for women who have typical symptoms of cystitis, who are at low risk for recurrent infection, and who do not have symptoms (such as vaginitis) suggesting other problems.
Oral antibiotic treatment cures nearly all uncomplicated UTIs, although the rate of recurrence remains high. To prescribe the best treatment, the doctor should be made aware of any drug allergies of the person.
The following antibiotics are commonly used for uncomplicated UTIs:
After a week of antibiotic treatment, most people are free of infection. If the symptoms do not clear up within the first few days of therapy, doctors generally suggest that women discontinue their antibiotic and provide a urine sample for culturing in order to identify the specific organism causing the condition.
It should be noted that resistance to many of the commonly used antibiotics is growing.
A relapsing infection (caused by treatment failure) occurs within 3 weeks in about 10% of women. Relapse is treated similarly to a first infection, but the antibiotics are usually continued for 7 to 14 days. Relapsing infections may be due to structural abnormalities, abscesses, or other problems that may require surgery. Such conditions should be ruled out.
Women who have 2 or more symptomatic UTIs within a 6-month period, or 3 or more episodes over the course of a year, may need preventive antibiotics. All women should use lifestyle measures to prevent recurrences.
Many, if not most, women with recurrent UTIs can effectively self-treat recurrent UTIs without going to a doctor. In general, this requires the following steps:
A woman should consult a doctor under the following circumstances:
Women who are not good candidates for self-treatment are those with impaired immune systems, previous kidney infections, structural abnormalities of the urinary tract, or a history of infection with antibiotic-resistant bacteria.
If recurrent infections are clearly related to sexual activity and episodes recur more than two times within a 6-month period, a single preventive dose taken immediately after intercourse is effective. Antibiotics for such cases include TMP-SMX, nitrofurantoin, cephalexin, or a fluoroquinolone (such as ciprofloxacin). (Fluoroquinolones are not appropriate during pregnancy.)
Continuous preventive (prophylactic) antibiotics are an option for some women who do not respond to other measures. With this approach, low-dose antibiotics are taken continuously for 6 months or longer.
People with uncomplicated kidney infections (pyelonephritis) may be treated at home with oral antibiotics. Ciprofloxacin (Cipro, generic) or another fluoroquinolone is typically given but other antibiotics, such as trimethoprim-sulfamethoxazole (TMP-SMX), may be used. People with moderate-to-severe acute kidney infection and those with severe symptoms or other complications may need to be hospitalized. In such cases, antibiotics are usually given intravenously for several days. Chronic pyelonephritis may require long-term antibiotic treatment.
Pregnant women should be screened for UTIs, since they are at high risk for UTIs and their complications. Antibiotics used for treating pregnant women with UTIs include amoxicillin, ampicillin, nitrofurantoin, and cephalosporins. Fosfomycin (Monurol) is not as effective as other antibiotics but is sometimes prescribed for pregnant women. In general, there is no consensus on which antibiotic is best for pregnant women although some types of antibiotics, such as fluoroquinolones and tetracyclines, should not be taken as they can cause harm to the fetus.
Pregnant women with asymptomatic bacteriuria (evidence of infection but no symptoms) have an increased risk for acute pyelonephritis in their second or third trimester. They need screening and treatment for this condition. In such cases, they should be treated with a short course of antibiotics (3 to 5 days). For an uncomplicated UTI, pregnant women may need longer-term antibiotics (7 to 10 days).
Children with UTIs are generally treated with TMP-SMX, cephalexin (Keflex, generic) and other cephalosporins, or amoxicillin/clavulanic acid (Augmentin, generic). These drugs are usually taken by mouth in either liquid or pill form. Doctors sometimes give them as a shot or IV. Children usually respond to treatment within a few days. Prompt treatment with antibiotics may help prevent renal scarring.
Vesicoureteral reflux (VUR) is a concern for children with UTIs. (See
Children with acute kidney infection are treated with various antibiotics including oral cefixime (Suprax) or a short course (2 to 4 days) of an intravenous (IV) antibiotic (typically gentamicin, given in one daily dose). An oral antibiotic then follows the IV.
Catheter-induced UTIs are very common, and preventive measures are extremely important. In-dwelling catheters should not be used unless absolutely necessary and they should be removed as soon as possible. Long-term catheter use is associated with increased risk for infections. For men, condom catheters may be an alternative to indwelling catheters.
A typical catheter comes pre-connected and sealed, and uses a drainage bag system. To prevent infection, some of the following tips may be helpful:
People using catheters who develop UTIs with symptoms should be treated for each episode with antibiotics and the catheter should be removed, if possible, or changed. A major problem in treating catheter-related UTIs is that the organisms involved are constantly changing. Because there are likely to be multiple species of bacteria, doctors generally recommend an antibiotic that is effective against a wide variety of microorganisms.
Although high bacteria counts in the urine (bacteriuria) occur in most catheterized people, administering antibiotics to prevent a UTI is rarely recommended. Many catheterized people do not develop symptomatic UTIs even with high bacteria counts. If bacteriuria occurs without symptoms, antibiotic therapy has little benefit if the catheter is to remain in place for a long period.
Catheterization is accomplished by inserting a catheter (a hollow tube, often with an inflatable balloon tip) into the urinary bladder. This procedure is performed for urinary obstruction, following surgical procedures to the urethra, in unconscious people (due to surgical anesthesia or coma), or for any other problem in which the bladder needs to be kept empty (decompressed) and urinary flow ensured.
Although antibiotics are the first treatment choice for UTIs, antibiotic-resistant strains of E. coli, the most common cause of UTIs, are increasing worldwide. As more bacteria have become resistant to the standard UTI treatment TMP-SMX, the antibiotics nitrofurantoin and fosfomycin have become alternative first-line choices for drug therapy.
Below are some of the antibiotic classes used most commonly to treat UTIs.
The typical treatment for an uncomplicated UTI is a 3-day course of the combination drug trimethoprim-sulfamethoxazole, commonly called TMP-SMX (Bactrim, Septra, and generic). A 1-day course is somewhat less effective but poses a lower risk for side effects. Longer courses (7 to 10 days) work no better than the 3-day course and have a higher rate of side effects.
TMP-SMX should not be used in people who are allergic to sulfa drugs. Allergic reactions can be very serious. Trimethoprim (Proloprim or Trimpex) is sometimes used alone in those allergic to sulfa drugs. TMP-SMX can interfere with the effectiveness of oral contraceptives. High rates of bacterial resistance to TMP-SMX exist in many parts of the United States.
Nitrofurantoin (Furadantin, Macrodantin, Macrobid, and generic) is an antibiotic that is used specifically for UTIs as an alternative to TMP-SMX. It is usually taken twice a day for 5 days. It is not useful for treating kidney infections. Nitrofurantoin frequently causes stomach upset and interacts with many drugs. Other chronic or serious medical conditions may also affect its use. It should not be used in pregnant women within 1 to 2 weeks of delivery, in nursing mothers, or in those with kidney disease.
The antibiotic fosfomycin (Monurol) may be prescribed as a 1-dose treatment for women who are pregnant or for other select people. In general, it is less effective for treating UTIs than TMP-SMX or nitrofurantoin.
Beta-lactam antibiotics share common chemical features and include penicillin, cephalosporins, and some newer drugs.
Until recent years, the standard treatment for a UTI was 10 days of amoxicillin, a penicillin antibiotic, but it is now ineffective against E. coli bacteria in many cases. A combination of amoxicillin-clavulanate (Augmentin) is sometimes given for drug-resistant infections.
Antibiotics known as cephalosporins are alternatives for infections that do not respond to standard treatments or for special populations. They are often classed as first, second, or third generation. Cephalosporins used for treatment of UTIs include cephalexin (Keflex, generic), cefadroxil (Duricef, generic), cefuroxime (Ceftin, generic), loracarbef (Lorabid), and cefixime (Suprax), among others.
Other beta-lactam antibiotics have been developed. For example, pivmecillinam (a form of mecillinam), is commonly used in Europe for UTIs. It is not available in the United States.
Fluoroquinolones (also simply called quinolones) were formerly used as alternatives to TMP-SMX but they are now recommended for UTIs only when other antibiotics are not appropriate. Fluoroquinolones are effective for treating acute kidney infections (pyelonephritis). Examples of quinolones include ofloxacin (Floxacin, generic), ciprofloxacin (Cipro, generic), and levofloxacin (Levaquin, generic). These drugs can have severe side effects that the person should discuss with the doctor.
Pregnant women should not take fluoroquinolone antibiotics. They also have more adverse effects in children than other antibiotics and should not be the first-line option in most pediatric situations.
Doripenem (Doribax) is a newer carbapenem antibiotic, which is used to treat complicated UTIs. It is given by injection.
Tetracyclines include doxycycline, tetracycline, and minocycline. They may be used for UTIs caused by Mycoplasma or Chlamydia. Side effects include skin reactions to sunlight and tooth discoloration. Tetracyclines cannot be taken by children or pregnant women.
Aminoglycosides include gentamicin, tobramycin, and amikacin. They are given by injection for very serious bacterial infections. They can be given only in combination with other antibiotics. Gentamicin is the most commonly used aminoglycoside for severe UTIs. They can have very serious side effects, including damage to hearing, sense of balance, and kidneys.
Although antibiotics can cure most UTIs, severe symptoms can persist for several days until the drug eliminates the bacteria. Other medications may be used for relieving symptoms until the antibiotics take action.
Phenazopyridine (Pyridium, Uristat, AZO Standard, Urodol, and generic) relieves pain and burning caused by the infection. People should not take this medicine for more than 2 days.
Side effects include headache and upset stomach. The drug turns urine a red or orange color, which can stain fabric and be difficult to remove. Rarely, it can cause serious side effects, including shortness of breath, a bluish skin, a sudden reduction in urine output, shortness of breath, and confusion. In such cases, people should immediately call the doctor.
Methenamine (Urised, Cystex, and generic) or flavoxate (Urispas, generic) reduce bladder spasms, which may occur with some UTIs. However, these drugs can have severe side effects, which the person should discuss with the doctor.
Although there is no evidence that good hygiene makes a real difference in preventing UTIs, it is always a wise practice. The following are some hygiene tips for women:
Appropriate hygiene and cleanliness of the genital area may help reduce the chances of introducing bacteria through the urethra. Females are especially vulnerable to this, because the urethra is in close proximity to the rectum. The genitals should be cleaned and wiped from front to back to reduce the chance of dragging E. coli from the rectal area to the urethra.
Sexual intercourse is one of the most common risk factors for uncomplicated UTIs in women. In addition to abstaining from sex while you have a UTI, the following recommendations may reduce the risks from sexual activity:
Cranberries, blueberries, and lignonberry (European relative of the cranberry), are three fruits that appear to have protective properties against urinary tract infections. These fruits contain compounds called tannins (or proanthocyanadins). Tannins may prevent E. coli from adhering to cells in the urinary tract, thereby inhibiting infection.
Cranberry juice is the best-studied home remedy for UTIs. Many studies have indicated that cranberry juice may help decrease the number of symptomatic UTIs, especially for women with recurrent urinary tract infections. However, other studies and reviews suggest that cranberries provide little benefit.
It is not clear what the optimum dosage is for cranberries, or whether it is best to use juice or tablet form although some studies suggest that drinking juice is more effective than taking tablets. Some research recommends drinking at least 1 to 2 cups of cranberry juice daily or taking at least 300 to 400 mg in tablet form twice daily.
Probiotics are beneficial microorganisms that may protect against infections in the genital and urinary tracts. The best-known probiotics are the lactobacilli strains, such as Lactobacillus acidophilus, which is found in yogurt and other fermented milk products (kefir), as well as in dietary supplement capsules. The probiotics bifidobacteria and GG lactobacilli may also be helpful. Studies do not conclusively show a benefit for probiotics in preventing UTIs. More research is needed.
American Academy of Pediatrics Task Force on Circumcision. Male circumcision. Pediatrics. 2012 Sep;130(3):e756-85. Epub 2012 Aug 27. PMID: 22926175 www.ncbi.nlm.nih.gov/pubmed/22926175.
Beerepoot MA, ter Riet G, Nys S, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012 May 14;172(9):704-12. PMID: 22782199 www.ncbi.nlm.nih.gov/pubmed/22782199.
Coulthard MG, Lambert HJ, Vernon SJ, et al. Does prompt treatment of urinary tract infection in preschool children prevent renal scarring: mixed retrospective and prospective audits. Arch Dis Child. 2014 Apr;99(4):342-7. Epub 2013 Dec 18. PMID: 24351607 www.ncbi.nlm.nih.gov/pubmed/24351607.
Elder JS. Urinary tract infections. In: Kliegman RM, Stanton BMD, Geme J, et al., eds. Nelson Textbook of Pediatrics. 20th ed. Philadelphia, PA: Elsevier; 2016:ch 538;2556-62.
Elder JS. Vesicoureteral reflux. In: Kliegman RM, Stanton BMD, St. Geme J, et al., eds. Nelson Textbook of Pediatrics. 20th ed. Philadelphia, PA: Elsevier; 2016:ch 539;2562-7.
Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011 Mar;52(5):e103-20. PMID: 21292654 www.ncbi.nlm.nih.gov/pubmed/21292654.
Gupta K, Trautner B. In the clinic. Urinary tract infection. Ann Intern Med. 2012 Mar 6;156(5):ITC3-1-ITC3-15. PMID: 22393148 www.ncbi.nlm.nih.gov/pubmed/22393148.
Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med. 2012 Mar 15;366(11):1028-37. PMID: 22417256 www.ncbi.nlm.nih.gov/pubmed/22417256.
Hooton TM. Nosocomial urinary tract infections. In: Bennett JE, Dolin R, Blaser MJ., eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed. Philadelphia, PA: Elsevier Saunders; 2015:ch 303;3334-46.
Keren R, Shaikh N, Pohl H, et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics. 2015 Jul;136(1):e13-21. Epub 2015 Jun 8. PMID: 26055855 www.ncbi.nlm.nih.gov/pubmed/26055855.
Mody L, Juthani-Mehta M. Urinary tract infections in older women: a clinical review. JAMA. 2014 Feb 26;311(8):844-54. PMID: 24570248 www.ncbi.nlm.nih.gov/pubmed/24570248.
Montini G, Tullus K, Hewitt I. Febrile urinary tract infections in children. N Engl J Med. 2011 Jul 21;365(3):239-50. PMID: 21774712 www.ncbi.nlm.nih.gov/pubmed/21774712.
Morris BJ, Wiswell TE. Circumcision and lifetime risk of urinary tract infection: a systematic review and meta-analysis. J Urol. 2013 Jun;189(6):2118-24. Epub 2012 Nov 28. PMID: 23201382 www.ncbi.nlm.nih.gov/pubmed/23201382.
RIVUR Trial Investigators, Hoberman A, Greenfield SP, Mattoo TK, Keren R, Mathews R, et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med. 2014 Jun 19;370(25):2367-76. Epub 2014 May 4. PMID: 24795142 www.ncbi.nlm.nih.gov/pubmed/24795142
Sobel JD, Kaye D. Urinary tract infections. In: Bennett JE, Dolin R, Blaser MJ., eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th. Philadelphia, PA: Elsevier Saunders; 2015:ch 73;886-913.
Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB, Downs SM, et al. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2011 Sep;128(3):595-610. Epub 2011 Aug 28. PMID: 21873693 www.ncbi.nlm.nih.gov/pubmed/21873693.
Wang CH, Fang CC, Chen NC, et al. Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2012 Jul 9;172(13):988-96. PMID: 22777630 www.ncbi.nlm.nih.gov/pubmed/22777630.
Reviewed By: Scott Miller, MD, urologist in private practice in Atlanta, GA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.